Kerstin Römermann

1.4k total citations
30 papers, 1.1k citations indexed

About

Kerstin Römermann is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Kerstin Römermann has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Psychiatry and Mental health, 18 papers in Pediatrics, Perinatology and Child Health and 17 papers in Oncology. Recurrent topics in Kerstin Römermann's work include Epilepsy research and treatment (19 papers), Drug Transport and Resistance Mechanisms (17 papers) and Pharmacological Effects and Toxicity Studies (15 papers). Kerstin Römermann is often cited by papers focused on Epilepsy research and treatment (19 papers), Drug Transport and Resistance Mechanisms (17 papers) and Pharmacological Effects and Toxicity Studies (15 papers). Kerstin Römermann collaborates with scholars based in Germany, Austria and Finland. Kerstin Römermann's co-authors include Wolfgang Löscher, Maren Fedrowitz, Marion Bankstahl, Kathrin Töllner, Oliver Langer, Markus Müller, Carlos Luna‐Tortós, Renate Helmer, Claudia Brandt and Thomas Erker and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Kerstin Römermann

29 papers receiving 1.1k citations

Peers

Countries citing papers authored by Kerstin Römermann

Since Specialization

Citations

This map shows the geographic impact of Kerstin Römermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerstin Römermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerstin Römermann more than expected).

Fields of papers citing papers by Kerstin Römermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerstin Römermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerstin Römermann. The network helps show where Kerstin Römermann may publish in the future.

Co-authorship network of co-authors of Kerstin Römermann

This figure shows the co-authorship network connecting the top 25 collaborators of Kerstin Römermann. A scholar is included among the top collaborators of Kerstin Römermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerstin Römermann. Kerstin Römermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Deletion of the Na-K-2Cl cotransporter NKCC1 results in a more severe epileptic phenotype in the intrahippocampal kainate mouse model of temporal lobe epilepsy 2021 ·Neurobiology of Disease ·(unknown), (unknown), (unknown), (unknown), (unknown), Birthe Gericke, Kathrin Töllner, Wiebke Theilmann, Christopher Käufer, Kerstin Römermann, Kai Kaila, Wolfgang Löscher	11
2	A combination of phenobarbital and the bumetanide derivative bumepamine prevents neonatal seizures and subsequent hippocampal neurodegeneration in a rat model of birth asphyxia 2021 ·Epilepsia ·(unknown), Christopher Käufer, Kerstin Römermann, (unknown), Birthe Gericke, Wolfgang Löscher	23
3	Phenobarbital and midazolam suppress neonatal seizures in a noninvasive rat model of birth asphyxia, whereas bumetanide is ineffective 2020 ·Epilepsia ·(unknown), Kerstin Römermann, (unknown), (unknown), Wiebke Theilmann, (unknown), Kai Kaila, Wolfgang Löscher	32
4	The search for brain-permeant NKCC1 inhibitors for the treatment of seizures: Pharmacokinetic-pharmacodynamic modelling of NKCC1 inhibition by azosemide, torasemide, and bumetanide in mouse brain 2020 ·Epilepsy & Behavior ·(unknown), Kerstin Römermann, (unknown), Wolfgang Löscher	24
5	A face-to-face comparison of claudin-5 transduced human brain endothelial (hCMEC/D3) cells with porcine brain endothelial cells as blood–brain barrier models for drug transport studies 2020 ·Fluids and Barriers of the CNS ·Birthe Gericke, Kerstin Römermann, Andreas Noack, Sandra Noack, (unknown), Ingolf E. Blasig, Wolfgang Löscher	24
6	Azosemide is more potent than bumetanide and various other loop diuretics to inhibit the sodium-potassium-chloride-cotransporter human variants hNKCC1A and hNKCC1B 2018 ·Scientific Reports ·(unknown), Kerstin Römermann, Nanna MacAulay, Wolfgang Löscher	34
7	Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's anti-seizure efficacy 2018 ·Neuropharmacology ·Claudia Brandt, Patricia Seja, Kathrin Töllner, Kerstin Römermann, (unknown), Markus Kalesse, (unknown), Peter W. Feit, (unknown), Trine L. Toft‐Bertelsen, (unknown), (unknown), Martin Puskarjov, Nanna MacAulay, Kai Kaila, Wolfgang Löscher	37
8	Multiple blood-brain barrier transport mechanisms limit bumetanide accumulation, and therapeutic potential, in the mammalian brain 2017 ·Neuropharmacology ·Kerstin Römermann, Maren Fedrowitz, (unknown), (unknown), Kathrin Töllner, Thomas Erker, Douglas H. Sweet, Wolfgang Löscher	58
9	A combination of NMDA and AMPA receptor antagonists retards granule cell dispersion and epileptogenesis in a model of acquired epilepsy 2017 ·Scientific Reports ·(unknown), Friederike Twele, (unknown), (unknown), Kerstin Römermann, Sonja Bröer, Sebastian Meller, Ingo Gerhauser, Vladan Rankovic, Dandan Li, Claudia Brandt, Marion Bankstahl, Kathrin Töllner, Wolfgang Löscher	31
10	Influence of 24-Nor-Ursodeoxycholic Acid on Hepatic Disposition of [18F]Ciprofloxacin, a Positron Emission Tomography Study in Mice 2016 ·Journal of Pharmaceutical Sciences ·Thomas Wanek, Emina Halilbasic, Michele Visentin, Severin Mairinger, Kerstin Römermann, Bruno Stieger, Claudia Kuntner, Markus Müller, Oliver Langer, Michael Trauner	5
11	Knockout of P-glycoprotein does not alter antiepileptic drug efficacy in the intrahippocampal kainate model of mesial temporal lobe epilepsy in mice 2016 ·Neuropharmacology ·Marion Bankstahl, Sabine Klein, Kerstin Römermann, Wolfgang Löscher	16
12	Network pharmacology for antiepileptogenesis: Tolerability of multitargeted drug combinations in nonepileptic vs. post-status epilepticus mice 2015 ·Epilepsy Research ·(unknown), Kathrin Töllner, Vladan Rankovic, Kerstin Römermann, (unknown), Marion Bankstahl, Wolfgang Löscher	27
13	The antiepileptic drug lamotrigine is a substrate of mouse and human breast cancer resistance protein (ABCG2) 2015 ·Neuropharmacology ·Kerstin Römermann, Renate Helmer, Wolfgang Löscher	68
14	Pilocarpine-Induced Convulsive Activity Is Limited by Multidrug Transporters at the Rodent Blood-Brain Barrier 2015 ·Journal of Pharmacology and Experimental Therapeutics ·Kerstin Römermann, Jens P. Bankstahl, Wolfgang Löscher, Marion Bankstahl	14
15	Approaching Complete Inhibition of P-Glycoprotein at the Human Blood–Brain Barrier: An (R)-[¹¹C]Verapamil PET Study 2015 ·Journal of Cerebral Blood Flow & Metabolism ·Martin Bauer, Rudolf Karch, Markus Zeitlinger, C. Philippe, Kerstin Römermann, Johann Stanek, Alexandra Maier‐Salamon, Wolfgang Wadsak, Walter Jäger, Marcus Hacker, Markus Müller, Oliver Langer	70
16	Marked Differences in the Effect of Antiepileptic and Cytostatic Drugs on the Functionality of P-Glycoprotein in Human and Rat Brain Capillary Endothelial Cell Lines 2014 ·Pharmaceutical Research ·(unknown), Maren Fedrowitz, Kerstin Römermann, Andreas Noack, Wolfgang Löscher	18
17	(R)-[11C]verapamil is selectively transported by murine and human P-glycoprotein at the blood–brain barrier, and not by MRP1 and BCRP 2013 ·Nuclear Medicine and Biology ·Kerstin Römermann, Thomas Wanek, Marion Bankstahl, Jens P. Bankstahl, Maren Fedrowitz, Markus Müller, Wolfgang Löscher, Claudia Kuntner, Oliver Langer	64
18	Tariquidar and Elacridar Are Dose-Dependently Transported by P-Glycoprotein and Bcrp at the Blood-Brain Barrier: A Small-Animal Positron Emission Tomography and In Vitro Study 2013 ·Drug Metabolism and Disposition ·Jens P. Bankstahl, Marion Bankstahl, Kerstin Römermann, Thomas Wanek, Johann Stanek, Albert D. Windhorst, Maren Fedrowitz, Thomas Erker, Markus Müller, Wolfgang Löscher, Oliver Langer, Claudia Kuntner	83
19	The antiepileptic drug mephobarbital is not transported by P-glycoprotein or multidrug resistance protein 1 at the blood–brain barrier: A positron emission tomography study 2012 ·Epilepsy Research ·Severin Mairinger, Jens P. Bankstahl, Claudia Kuntner, Kerstin Römermann, Marion Bankstahl, Thomas Wanek, Johann Stanek, Wolfgang Löscher, Markus Müller, Thomas Erker, Oliver Langer	10
20	Do ATP-Binding Cassette Transporters Cause Pharmacoresistance in Epilepsy? Problems and Approaches in Determining which Antiepileptic Drugs are Affected 2011 ·Current Pharmaceutical Design ·Wolfgang Löscher, Carlos Luna‐Tortós, Kerstin Römermann, Maren Fedrowitz	97

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact